ArmaGen Technologies

formerly ARMAGEN TECHNOLOGIES, INC.

ArmaGen Technologies is a biotech company in Calabasas, United States, founded in 2004. It has raised $17.0M across 1 round, most recently a $17.0M Series A in November 2012.

Employees
11–50
Founded
2004
Business Model
B2B
Total Funding
$17.0M
Last Round
$17.0M Series ANov 2012
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

ArmaGen Technologies (now ArmaGen, Inc.) was a clinical-stage biotechnology company focused on developing therapies for severe neurological disorders, specifically targeting the challenge of crossing the blood-brain barrier. Founded in 2004 by Dr. William M. Pardridge, the company pioneered receptor-mediated transcytosis technology, fusing therapeutics to antibodies that bind insulin or transferrin receptors to enable brain delivery. ArmaGen built a pipeline for lysosomal storage disorders including Hurler syndrome (MPS I), Hunter syndrome (MPS II), metachromatic leukodystrophy, and Sanfilippo syndromes. The company was acquired by JCR Pharmaceuticals in March 2020.

Summary

It lists 11–50 employees. It has raised $17.0M in total across 1 round, most recently a $17.0M Series A round in Nov 2012. Investors include Boehringer Ingelheim Venture Fund, Shire plc and Takeda (JP).

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ANov 2012
$17.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ArmaGen Technologies on Indexed.vc
<a href="https://indexed.vc/companies/armagen-technologies"><img src="https://indexed.vc/api/badge/company/armagen-technologies" alt="ArmaGen Technologies on Indexed.vc" width="260" height="76" /></a>